263 related articles for article (PubMed ID: 38203502)
1. Consideration of SHP-1 as a Molecular Target for Tumor Therapy.
Lim S; Lee KW; Kim JY; Kim KD
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203502
[TBL] [Abstract][Full Text] [Related]
2. Src homology region 2 (SH2) domain-containing phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells.
Mizuno K; Tagawa Y; Mitomo K; Arimura Y; Hatano N; Katagiri T; Ogimoto M; Yakura H
J Immunol; 2000 Aug; 165(3):1344-51. PubMed ID: 10903736
[TBL] [Abstract][Full Text] [Related]
3. Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells.
Kim H; Baumann H
Mol Cell Biol; 1999 Aug; 19(8):5326-38. PubMed ID: 10409724
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel Src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinoma.
Tai WT; Shiau CW; Chen PJ; Chu PY; Huang HP; Liu CY; Huang JW; Chen KF
Hepatology; 2014 Jan; 59(1):190-201. PubMed ID: 23908138
[TBL] [Abstract][Full Text] [Related]
5. Direct association with and dephosphorylation of Jak2 kinase by the SH2-domain-containing protein tyrosine phosphatase SHP-1.
Jiao H; Berrada K; Yang W; Tabrizi M; Platanias LC; Yi T
Mol Cell Biol; 1996 Dec; 16(12):6985-92. PubMed ID: 8943354
[TBL] [Abstract][Full Text] [Related]
6. Recruitment of SH2-containing protein tyrosine phosphatase SHP-1 to the interleukin 2 receptor; loss of SHP-1 expression in human T-lymphotropic virus type I-transformed T cells.
Migone TS; Cacalano NA; Taylor N; Yi T; Waldmann TA; Johnston JA
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3845-50. PubMed ID: 9520455
[TBL] [Abstract][Full Text] [Related]
7. Targeting Src homology 2 domain-containing tyrosine phosphatase (SHP-1) into lipid rafts inhibits CD3-induced T cell activation.
Su MW; Yu CL; Burakoff SJ; Jin YJ
J Immunol; 2001 Mar; 166(6):3975-82. PubMed ID: 11238643
[TBL] [Abstract][Full Text] [Related]
8. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
9. The novel role of the C-terminal region of SHP-2. Involvement of Gab1 and SHP-2 phosphatase activity in Elk-1 activation.
Huang Q; Lerner-Marmarosh N; Che W; Ohta S; Osawa M; Yoshizumi M; Glassman M; Yan C; Berk BC; Abe J
J Biol Chem; 2002 Aug; 277(32):29330-41. PubMed ID: 12011040
[TBL] [Abstract][Full Text] [Related]
10. Effects of Src homology domain 2 (SH2)-containing inositol phosphatase (SHIP), SH2-containing phosphotyrosine phosphatase (SHP)-1, and SHP-2 SH2 decoy proteins on Fc gamma RIIB1-effector interactions and inhibitory functions.
Nakamura K; Brauweiler A; Cambier JC
J Immunol; 2000 Jan; 164(2):631-8. PubMed ID: 10623804
[TBL] [Abstract][Full Text] [Related]
11. Raft-mediated Src homology 2 domain-containing proteintyrosine phosphatase 2 (SHP-2) regulation in microglia.
Kim HY; Park SJ; Joe EH; Jou I
J Biol Chem; 2006 Apr; 281(17):11872-8. PubMed ID: 16507579
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of human protein tyrosine phosphatase SHP-1 in the open conformation.
Wang W; Liu L; Song X; Mo Y; Komma C; Bellamy HD; Zhao ZJ; Zhou GW
J Cell Biochem; 2011 Aug; 112(8):2062-71. PubMed ID: 21465528
[TBL] [Abstract][Full Text] [Related]
13. Oxidation sensitivity of the catalytic cysteine of the protein-tyrosine phosphatases SHP-1 and SHP-2.
Weibrecht I; Böhmer SA; Dagnell M; Kappert K; Ostman A; Böhmer FD
Free Radic Biol Med; 2007 Jul; 43(1):100-10. PubMed ID: 17561098
[TBL] [Abstract][Full Text] [Related]
14. Murine SHP-1 splice variants with altered Src homology 2 (SH2) domains. Implications for the SH2-mediated intramolecular regulation of SHP-1.
Martin A; Tsui HW; Shulman MJ; Isenman D; Tsui FW
J Biol Chem; 1999 Jul; 274(31):21725-34. PubMed ID: 10419485
[TBL] [Abstract][Full Text] [Related]
15. Fyn kinase-directed activation of SH2 domain-containing protein-tyrosine phosphatase SHP-2 by Gi protein-coupled receptors in Madin-Darby canine kidney cells.
Tang H; Zhao ZJ; Huang XY; Landon EJ; Inagami T
J Biol Chem; 1999 Apr; 274(18):12401-7. PubMed ID: 10212213
[TBL] [Abstract][Full Text] [Related]
16. SHP-1 tyrosine phosphatase binding to c-Src kinase phosphor-dependent conformations: A comparative structural framework.
Gul M; Navid A; Fakhar M; Rashid S
PLoS One; 2023; 18(1):e0278448. PubMed ID: 36638102
[TBL] [Abstract][Full Text] [Related]
17. Leptin receptor activation of SH2 domain containing protein tyrosine phosphatase 2 modulates Ob receptor signal transduction.
Li C; Friedman JM
Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9677-82. PubMed ID: 10449753
[TBL] [Abstract][Full Text] [Related]
18. Molecular dynamics simulations on the free and complexed N-terminal SH2 domain of SHP-2.
Wieligmann K; Pineda De Castro LF; Zacharias M
In Silico Biol; 2002; 2(3):305-11. PubMed ID: 12542415
[TBL] [Abstract][Full Text] [Related]
19. Protein tyrosine phosphatase SHP-2: a proto-oncogene product that promotes Ras activation.
Matozaki T; Murata Y; Saito Y; Okazawa H; Ohnishi H
Cancer Sci; 2009 Oct; 100(10):1786-93. PubMed ID: 19622105
[TBL] [Abstract][Full Text] [Related]
20. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors.
Wu CJ; O'Rourke DM; Feng GS; Johnson GR; Wang Q; Greene MI
Oncogene; 2001 Sep; 20(42):6018-25. PubMed ID: 11593409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
